News
VMTHF
0.422
NaN%
--
Weekly Report: what happened at VMTHF last week (0908-0912)?
Weekly Report · 09/15/2025 09:56
Weekly Report: what happened at VMTHF last week (0901-0905)?
Weekly Report · 09/08/2025 09:57
Weekly Report: what happened at VMTHF last week (0825-0829)?
Weekly Report · 09/01/2025 09:55
Weekly Report: what happened at VMTHF last week (0818-0822)?
Weekly Report · 08/25/2025 09:59
Weekly Report: what happened at VMTHF last week (0811-0815)?
Weekly Report · 08/18/2025 09:56
Weekly Report: what happened at VMTHF last week (0804-0808)?
Weekly Report · 08/11/2025 09:58
Weekly Report: what happened at VMTHF last week (0728-0801)?
Weekly Report · 08/04/2025 10:00
Weekly Report: what happened at VMTHF last week (0721-0725)?
Weekly Report · 07/28/2025 10:00
Weekly Report: what happened at VMTHF last week (0714-0718)?
Weekly Report · 07/21/2025 09:56
Weekly Report: what happened at VMTHF last week (0707-0711)?
Weekly Report · 07/14/2025 10:00
Weekly Report: what happened at VMTHF last week (0630-0704)?
Weekly Report · 07/07/2025 09:56
More
Webull provides a variety of real-time VMTHF stock news. You can receive the latest news about Venus Medtech through multiple platforms. This information may help you make smarter investment decisions.
About VMTHF
Venus Medtech (Hangzhou) Inc is a China-based company primarily engaged in the research, development, production, and sales of biological heart valves. The Company focuses on the field of structural heart disease. The Company's products include a series of interventional devices for heart valve diseases, such as transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), transcatheter mitral valve replacement (TMVR), and transcatheter tricuspid valve replacement (TTVR), as well as surgical consumables. The Company distributes its products within the domestic market and to overseas markets.